Literature DB >> 12052575

Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder.

Virginija Novak-Grubic1, Rok Tavcar.   

Abstract

PURPOSE: Many factors influencing compliance in schizophrenia have been reported in the literature. Our aim was to assess predictors of noncompliance in male patients with first-episode schizophrenia, schizophreniform and schizoaffective disorder in a naturalistic setting. SUBJECTS AND METHODS: Fifty-six male patients, discharged from hospital, were included in a 1-year follow-up study. Psychopathological symptoms were assessed with positive and negative syndrome scale at admission and discharge, while extrapyramidal side effects were recorded weekly during hospitalisation using the Simpson-Angus and Barnes akathisia scales. Socio-demographic and some other variables were also recorded.
RESULTS: Thirty patients (53.6%) dropped out of treatment in the first year and 21 of them relapsed. With the Cox survival analysis three predictors of noncompliance were found: diagnosis of schizophrenia versus the other two diagnoses, positive symptoms at admission, and lack of insight at discharge. Discussion. In spite of a specific methodology and selection of only first-episode male patients, the results are in accordance with the findings of other authors. This confirms the universality of noncompliance in psychotic patients.
CONCLUSIONS: First-episode patients have a high dropout rate. However, in compliant patients, the relapse rate was low, and therefore special attention and compliance-promoting interventions in first-episode patients are needed.

Entities:  

Mesh:

Year:  2002        PMID: 12052575     DOI: 10.1016/s0924-9338(02)00645-4

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  18 in total

1.  The patient's perspective on medicines in mental illness.

Authors:  Mike Shooter
Journal:  BMJ       Date:  2003-10-11

2.  One year outcome in first episode schizophrenia. Predictors of relapse.

Authors:  Alp Uçok; Aslihan Polat; Sibel Cakir; Aysun Genç
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-07-18       Impact factor: 5.270

Review 3.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

Review 4.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

5.  Open-ended and Open-door Treatment Groups for Young People with Mental Illness.

Authors:  Rachel Miller; Susan E Mason
Journal:  Soc Work Groups       Date:  2012

6.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

7.  Effectiveness of Community Treatment Order in Patients with a First Episode of Psychosis: A Mirror-Image Study.

Authors:  Emmanuelle Levy; Sally Mustafa; Kanza Naveed; Ridha Joober
Journal:  Can J Psychiatry       Date:  2018-08-05       Impact factor: 4.356

8.  A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.

Authors:  Rachel Miller; Geoffrey Ream; Joanne McCormack; Handan Gunduz-Bruce; Serge Sevy; Delbert Robinson
Journal:  Schizophr Res       Date:  2009-05-28       Impact factor: 4.939

9.  Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

Authors:  Leslie Citrome
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

10.  Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.

Authors:  José Manuel Olivares; Köksal Alptekin; Jean-Michel Azorin; Fernando Cañas; Vincent Dubois; Robin Emsley; Philip Gorwood; Peter M Haddad; Dieter Naber; George Papageorgiou; Miquel Roca; Pierre Thomas; Guadalupe Martinez; Andreas Schreiner
Journal:  Patient Prefer Adherence       Date:  2013-01-30       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.